Published in Clin Pharmacol Ther on May 30, 2017
Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet (2008) 11.80
Human hypertension caused by mutations in WNK kinases. Science (2001) 8.71
Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet (1996) 5.95
Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell (1994) 5.29
Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med (2009) 4.96
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial. JAMA (2015) 4.63
Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet (1997) 4.43
Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature (2012) 4.26
WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem (2000) 3.97
Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet (1996) 3.58
Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1. J Cell Sci (2008) 3.07
Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc Natl Acad Sci U S A (2001) 2.97
Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet (2001) 2.87
SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction. J Am Soc Nephrol (2010) 2.73
Urinary concentrating defect in mice with selective deletion of phloretin-sensitive urea transporters in the renal collecting duct. Proc Natl Acad Sci U S A (2004) 2.68
Salt wasting and deafness resulting from mutations in two chloride channels. N Engl J Med (2004) 2.57
WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene (2001) 2.48
Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc Natl Acad Sci U S A (2009) 2.41
The Na+-dependent chloride-bicarbonate exchanger SLC4A8 mediates an electroneutral Na+ reabsorption process in the renal cortical collecting ducts of mice. J Clin Invest (2010) 2.28
Maxi-K channels contribute to urinary potassium excretion in the ROMK-deficient mouse model of Type II Bartter's syndrome and in adaptation to a high-K diet. Kidney Int (2006) 2.22
Dominant-negative regulation of WNK1 by its kidney-specific kinase-defective isoform. Am J Physiol Renal Physiol (2005) 2.06
cAMP increases surface expression of NKCC2 in rat thick ascending limbs: role of VAMP. Am J Physiol Renal Physiol (2005) 2.00
Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport. J Clin Invest (2005) 1.96
Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms. Proc Natl Acad Sci U S A (2006) 1.93
KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet (2012) 1.93
Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. Nat Genet (1999) 1.83
Crystal structure of the kinase domain of WNK1, a kinase that causes a hereditary form of hypertension. Structure (2004) 1.82
Urea-selective concentrating defect in transgenic mice lacking urea transporter UT-B. J Biol Chem (2002) 1.79
Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet (1998) 1.73
Bartter syndrome. Curr Opin Nephrol Hypertens (2003) 1.72
Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo. J Am Soc Nephrol (2006) 1.65
Potassium modulates electrolyte balance and blood pressure through effects on distal cell voltage and chloride. Cell Metab (2015) 1.59
Alternatively spliced proline-rich cassettes link WNK1 to aldosterone action. J Clin Invest (2015) 1.53
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease. Eur Heart J (2016) 1.52
NaCl restriction upregulates renal Slc26a4 through subcellular redistribution: role in Cl- conservation. Hypertension (2004) 1.49
Impaired urea accumulation in the inner medulla of mice lacking the urea transporter UT-A2. Mol Cell Biol (2005) 1.47
Salt-losing nephropathy in mice with a null mutation of the Clcnk2 gene. Acta Physiol (Oxf) (2016) 1.45
Chloride sensing by WNK1 involves inhibition of autophosphorylation. Sci Signal (2014) 1.33
Pendrin modulates ENaC function by changing luminal HCO3-. J Am Soc Nephrol (2010) 1.29
Urinary concentrating ability in patients with Jk(a-b-) blood type who lack carrier-mediated urea transport. J Am Soc Nephrol (1992) 1.29
Impaired phosphorylation of Na(+)-K(+)-2Cl(-) cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome. Proc Natl Acad Sci U S A (2011) 1.25
Triazolothienopyrimidine inhibitors of urea transporter UT-B reduce urine concentration. J Am Soc Nephrol (2012) 1.22
Pendrin regulation in mouse kidney primarily is chloride-dependent. J Am Soc Nephrol (2006) 1.19
Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension. Proc Natl Acad Sci U S A (2010) 1.18
Double knockout of pendrin and Na-Cl cotransporter (NCC) causes severe salt wasting, volume depletion, and renal failure. Proc Natl Acad Sci U S A (2012) 1.16
KCNJ10 determines the expression of the apical Na-Cl cotransporter (NCC) in the early distal convoluted tubule (DCT1). Proc Natl Acad Sci U S A (2014) 1.13
The Effect of WNK4 on the Na+-Cl- Cotransporter Is Modulated by Intracellular Chloride. J Am Soc Nephrol (2014) 1.12
Endothelial-specific expression of WNK1 kinase is essential for angiogenesis and heart development in mice. Am J Pathol (2009) 1.12
Advances in understanding the urine-concentrating mechanism. Annu Rev Physiol (2013) 1.11
A novel small-molecule thienoquinolin urea transporter inhibitor acts as a potential diuretic. Kidney Int (2013) 1.11
Cl- channels of the distal nephron. Am J Physiol Renal Physiol (2006) 1.07
Activation of PI3-kinase stimulates endocytosis of ROMK via Akt1/SGK1-dependent phosphorylation of WNK1. J Am Soc Nephrol (2011) 1.05
Unique chloride-sensing properties of WNK4 permit the distal nephron to modulate potassium homeostasis. Kidney Int (2016) 1.05
Profound hypokalemia and hypochloremic metabolic alkalosis during thiazide therapy in a child with Pendred syndrome. Clin Nephrol (2008) 1.03
Nonsteroidal antagonists of the mineralocorticoid receptor. Curr Opin Nephrol Hypertens (2015) 1.01
Role of thin descending limb urea transport in renal urea handling and the urine concentrating mechanism. Am J Physiol Renal Physiol (2011) 1.00
Pharmacologic inhibition of the renal outer medullary potassium channel causes diuresis and natriuresis in the absence of kaliuresis. J Pharmacol Exp Ther (2013) 0.99
Serum and glucocorticoid-induced kinase (SGK) 1 and the epithelial sodium channel are regulated by multiple with no lysine (WNK) family members. J Biol Chem (2010) 0.99
Hypertension resistance polymorphisms in ROMK (Kir1.1) alter channel function by different mechanisms. Am J Physiol Renal Physiol (2010) 0.98
Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models. Hum Mol Genet (2010) 0.98
Epithelial sodium transport and its control by aldosterone: the story of our internal environment revisited. Physiol Rev (2015) 0.97
Direct and Indirect Mineralocorticoid Effects Determine Distal Salt Transport. J Am Soc Nephrol (2015) 0.96
Integrated compensatory network is activated in the absence of NCC phosphorylation. J Clin Invest (2015) 0.96
Angiotensin II signaling via protein kinase C phosphorylates Kelch-like 3, preventing WNK4 degradation. Proc Natl Acad Sci U S A (2014) 0.95
Unique natriuretic properties of the ATP-sensitive K(+)-channel blocker glyburide in conscious rats. J Pharmacol Exp Ther (1993) 0.94
Diuresis and reduced urinary osmolality in rats produced by small-molecule UT-A-selective urea transport inhibitors. FASEB J (2014) 0.93
Cortical distal nephron Cl(-) transport in volume homeostasis and blood pressure regulation. Am J Physiol Renal Physiol (2013) 0.92
Chemical library screening for WNK signalling inhibitors using fluorescence correlation spectroscopy. Biochem J (2013) 0.91
Cl- absorption across the thick ascending limb is not altered in cystic fibrosis mice. A role for a pseudo-CFTR Cl- channel. J Clin Invest (1998) 0.90
Extracellular K(+) rapidly controls NaCl cotransporter phosphorylation in the native distal convoluted tubule by Cl(-) -dependent and independent mechanisms. J Physiol (2016) 0.89
A minor role of WNK3 in regulating phosphorylation of renal NKCC2 and NCC co-transporters in vivo. Biol Open (2011) 0.88
Discovery of Novel SPAK Inhibitors That Block WNK Kinase Signaling to Cation Chloride Transporters. J Am Soc Nephrol (2014) 0.88
Genetic variation in the human urea transporter-2 is associated with variation in blood pressure. Hum Mol Genet (2001) 0.87
Spatial organization of the vascular bundle and the interbundle region: three-dimensional reconstruction at the inner stripe of the outer medulla in the mouse kidney. Am J Physiol Renal Physiol (2013) 0.86
Urea channel inhibitors: a new functional class of aquaretics. Kidney Int (2013) 0.86
Novel mechanisms of Na+ retention in obesity: phosphorylation of NKCC2 and regulation of SPAK/OSR1 by AMPK. Am J Physiol Renal Physiol (2014) 0.86
Functional severity of CLCNKB mutations correlates with phenotypes in patients with classic Bartter's syndrome. J Physiol (2017) 0.85
The multifaceted mineralocorticoid receptor. Compr Physiol (2014) 0.85
The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. J Am Soc Nephrol (2016) 0.84
Urea transporter proteins as targets for small-molecule diuretics. Nat Rev Nephrol (2014) 0.83
In-vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats: a new drug target for hypertension? J Hypertens (2012) 0.83
STE20/SPS1-related proline/alanine-rich kinase (SPAK) is critical for sodium reabsorption in isolated, perfused thick ascending limb. Am J Physiol Renal Physiol (2014) 0.81
Salt-sparing diuretic action of a water-soluble urea analog inhibitor of urea transporters UT-A and UT-B in rats. Kidney Int (2015) 0.81
Adult nephron-specific MR-deficient mice develop a severe renal PHA-1 phenotype. Pflugers Arch (2016) 0.81
Critical role of the SPAK protein kinase CCT domain in controlling blood pressure. Hum Mol Genet (2015) 0.81
Electroneutral NaCl transport in the distal tubule. Kidney Int (1989) 0.80
Disruption of KCNJ10 (Kir4.1) stimulates the expression of ENaC in the collecting duct. Am J Physiol Renal Physiol (2016) 0.80
Inhibitors of pendrin anion exchange identified in a small molecule screen increase airway surface liquid volume in cystic fibrosis. FASEB J (2016) 0.80
Electrolyte excretion as influenced by chlorothiazide. Science (1958) 0.79
Small-Molecule Inhibitors of Pendrin Potentiate the Diuretic Action of Furosemide. J Am Soc Nephrol (2016) 0.78
Small-molecule WNK inhibition regulates cardiovascular and renal function. Nat Chem Biol (2016) 0.77
Hypertension: the missing WNKs. Am J Physiol Renal Physiol (2016) 0.76
Synthetic approaches towards the multi target drug Spironolactone and its potent analogues/derivatives. Steroids (2016) 0.76
Rafoxanide and Closantel Inhibit SPAK and OSR1 Kinases by Binding to a Highly Conserved Allosteric Site on Their C-terminal Domains. ChemMedChem (2017) 0.76
Discovery and characterization of allosteric WNK kinase inhibitors. ACS Chem Biol (2016) 0.75
Generation and phenotypic analysis of mice lacking all urea transporters. Kidney Int (2016) 0.75
Potassium Sensing by Renal Distal Tubules Requires Kir4.1. J Am Soc Nephrol (2017) 0.75
Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart Failure. ACS Med Chem Lett (2016) 0.75